{"title":"香港华人肥厚性心肌病的遗传格局。","authors":"Derek P H Lee, Ye Cao, Lilei Zhang","doi":"10.3389/fgene.2025.1583838","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Asian populations are underrepresented in the hypertrophic cardiomyopathy (HCM) genomic databases, which are currently largely dominated by Caucasian population. We aim to characterize the genetic landscape of HCM in patients from Hong Kong Chinese population.</p><p><strong>Methods: </strong>From March 2023 to March 2024, fifty-three unrelated patients with an unequivocal clinical diagnosis of HCM were enrolled at a single tertiary center in Hong Kong and underwent genetic testing using a standardized 19-gene panel.</p><p><strong>Results: </strong>In this cohort study, we identified 13 patients (24.5%) with a predominant pathogenic or likely pathogenic (P/LP) variant and 12 patients (22.6%) with a predominant variant of unknown significance (VUS). Most of the P/LP variants identified were in <i>MYBPC3</i> (46.2%, n = 6) or <i>MYH7</i> (38.5%, n = 5). Novel genetic variants were identified in 5 patients. Multiple genetic variants identified in the same patient were common (13.2%, n = 7). All disease-causing variants are rare with allele frequencies <0.00005 in all populations and <0.0002 in East Asian subpopulation. Specifically in this unrelated cohort, we identified several recurrent variants including <i>MYH7</i>:c.1987C>T (p.Arg663Cys) pathogenic missense variant (n = 2), <i>MYBPC3</i>:c.1038_1042dup (p.Met348Thrfs*4) pathogenic truncating variant (n = 3) and <i>MYBPC3</i>:c.1000G>A (p.Glu334Lys) missense VUS (n = 3). Patients with P/LP variants were associated with an increased risk of developing left ventricular dysfunction (p = 0.012).</p><p><strong>Conclusion: </strong>Our study provided insight into the genetic landscape of HCM in Hong Kong Chinese population. We identified several recurrent variants and novel variants in our HCM cohort. Patients with P/LP variants were associated with an increased risk of developing left ventricular dysfunction. Future studies on the potential founder effects of these recurrent variants, cumulative effects of multiple variants, and longitudinal follow up of HCM patients would be useful.</p>","PeriodicalId":12750,"journal":{"name":"Frontiers in Genetics","volume":"16 ","pages":"1583838"},"PeriodicalIF":2.8000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12123433/pdf/","citationCount":"0","resultStr":"{\"title\":\"Genetic landscape of hypertrophic cardiomyopathy in Hong Kong Chinese population.\",\"authors\":\"Derek P H Lee, Ye Cao, Lilei Zhang\",\"doi\":\"10.3389/fgene.2025.1583838\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Asian populations are underrepresented in the hypertrophic cardiomyopathy (HCM) genomic databases, which are currently largely dominated by Caucasian population. We aim to characterize the genetic landscape of HCM in patients from Hong Kong Chinese population.</p><p><strong>Methods: </strong>From March 2023 to March 2024, fifty-three unrelated patients with an unequivocal clinical diagnosis of HCM were enrolled at a single tertiary center in Hong Kong and underwent genetic testing using a standardized 19-gene panel.</p><p><strong>Results: </strong>In this cohort study, we identified 13 patients (24.5%) with a predominant pathogenic or likely pathogenic (P/LP) variant and 12 patients (22.6%) with a predominant variant of unknown significance (VUS). Most of the P/LP variants identified were in <i>MYBPC3</i> (46.2%, n = 6) or <i>MYH7</i> (38.5%, n = 5). Novel genetic variants were identified in 5 patients. Multiple genetic variants identified in the same patient were common (13.2%, n = 7). All disease-causing variants are rare with allele frequencies <0.00005 in all populations and <0.0002 in East Asian subpopulation. Specifically in this unrelated cohort, we identified several recurrent variants including <i>MYH7</i>:c.1987C>T (p.Arg663Cys) pathogenic missense variant (n = 2), <i>MYBPC3</i>:c.1038_1042dup (p.Met348Thrfs*4) pathogenic truncating variant (n = 3) and <i>MYBPC3</i>:c.1000G>A (p.Glu334Lys) missense VUS (n = 3). Patients with P/LP variants were associated with an increased risk of developing left ventricular dysfunction (p = 0.012).</p><p><strong>Conclusion: </strong>Our study provided insight into the genetic landscape of HCM in Hong Kong Chinese population. We identified several recurrent variants and novel variants in our HCM cohort. Patients with P/LP variants were associated with an increased risk of developing left ventricular dysfunction. Future studies on the potential founder effects of these recurrent variants, cumulative effects of multiple variants, and longitudinal follow up of HCM patients would be useful.</p>\",\"PeriodicalId\":12750,\"journal\":{\"name\":\"Frontiers in Genetics\",\"volume\":\"16 \",\"pages\":\"1583838\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-05-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12123433/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Genetics\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.3389/fgene.2025.1583838\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Genetics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fgene.2025.1583838","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Genetic landscape of hypertrophic cardiomyopathy in Hong Kong Chinese population.
Introduction: Asian populations are underrepresented in the hypertrophic cardiomyopathy (HCM) genomic databases, which are currently largely dominated by Caucasian population. We aim to characterize the genetic landscape of HCM in patients from Hong Kong Chinese population.
Methods: From March 2023 to March 2024, fifty-three unrelated patients with an unequivocal clinical diagnosis of HCM were enrolled at a single tertiary center in Hong Kong and underwent genetic testing using a standardized 19-gene panel.
Results: In this cohort study, we identified 13 patients (24.5%) with a predominant pathogenic or likely pathogenic (P/LP) variant and 12 patients (22.6%) with a predominant variant of unknown significance (VUS). Most of the P/LP variants identified were in MYBPC3 (46.2%, n = 6) or MYH7 (38.5%, n = 5). Novel genetic variants were identified in 5 patients. Multiple genetic variants identified in the same patient were common (13.2%, n = 7). All disease-causing variants are rare with allele frequencies <0.00005 in all populations and <0.0002 in East Asian subpopulation. Specifically in this unrelated cohort, we identified several recurrent variants including MYH7:c.1987C>T (p.Arg663Cys) pathogenic missense variant (n = 2), MYBPC3:c.1038_1042dup (p.Met348Thrfs*4) pathogenic truncating variant (n = 3) and MYBPC3:c.1000G>A (p.Glu334Lys) missense VUS (n = 3). Patients with P/LP variants were associated with an increased risk of developing left ventricular dysfunction (p = 0.012).
Conclusion: Our study provided insight into the genetic landscape of HCM in Hong Kong Chinese population. We identified several recurrent variants and novel variants in our HCM cohort. Patients with P/LP variants were associated with an increased risk of developing left ventricular dysfunction. Future studies on the potential founder effects of these recurrent variants, cumulative effects of multiple variants, and longitudinal follow up of HCM patients would be useful.
Frontiers in GeneticsBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
5.50
自引率
8.10%
发文量
3491
审稿时长
14 weeks
期刊介绍:
Frontiers in Genetics publishes rigorously peer-reviewed research on genes and genomes relating to all the domains of life, from humans to plants to livestock and other model organisms. Led by an outstanding Editorial Board of the world’s leading experts, this multidisciplinary, open-access journal is at the forefront of communicating cutting-edge research to researchers, academics, clinicians, policy makers and the public.
The study of inheritance and the impact of the genome on various biological processes is well documented. However, the majority of discoveries are still to come. A new era is seeing major developments in the function and variability of the genome, the use of genetic and genomic tools and the analysis of the genetic basis of various biological phenomena.